News | SMA Europe

The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. SMA Europe responds to European neuromuscular experts’ consensus statements on gene replacement therapy for SMA

    A group of European neuromuscular experts presented eleven consensus statements covering qualification, patient selection, safety considerations and long-term monitoring, in order to aid the rational use of Zolgensma™ for the treatment of SMA (1). In a letter published in the European Journal of Paediatric Neurology (2), SMA Europe addresses these consensus statements by highlights: The […]

    READ MORE

  2. Roche provides the community with a summary of their 2020 work

    Roche has provided us with a summary of its work in the community throughout this year, including information about the risdiplam clinical development programme and progress towards their goal of making risdiplam available to all patients who can benefit from the treatment. Ensuring patient safety, uninterrupted access to treatment and to support the wider community: […]

    READ MORE